HTN App for HTN Control and Cardiovascular Health Among African-Americans

Overview

About this study

The purpose of this study is to test the hypertension (HTN) app-based intervention to see if it is more effective in improving uncontrolled HTN and HTN self-care among Africian-Americans from baseline to post-intervention (immediate, 3 months and 6 months post-intervention) as compared to the standard of care.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Afican-American (AA) adults that are established patients at Neighborhood HealthSource.
  • Receives primary care (i.e., has designated primary care provider) at the partnering FQHCs and intent to continue care there for next 6 months.
  • AA race/ethnicity.
  • Men and women aged ≥ 18 years.
  • Uncontrolled HTN (defined as BP ≥140/90 mmHg [as per JNC7 Hypertension Guidelines67] at most recent outpatient evaluation, with or without BP medications).
  • Documented diagnosis of HTN in EHR.
  • At least 1 office visit at the partnering FQHCs in the prior year.
  • Smartphone ownership (supporting iOS or Android Systems).
  • Active email address and willingness to utilize it throughout the study.
  • Basic Internet navigation skills (for example, can search for information on websites, open and send emails).
  • Access to the Internet on at least a weekly basis (such as at home, a family member’s or friend’s home, church, library/community center, school/university, Internet café, etc.).

Exclusion Criteria:

  • Diagnosis of a serious medical condition or disability that would make participation difficult (i.e. visual or hearing impairment, mental disability that would preclude independent use of the app).
  • No primary care provider at partnering FQHC.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 11/9/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

LaPrincess Brewer, M.D., M.P.H.

Open for enrollment

Contact information:

Lainey Moen M.A.

(507) 266-7062

Moen.Lainey@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20565301

Mayo Clinic Footer